Search

Author/Creator Jansen, T L

1. 2016 updated EULAR evidence-based recommendations for the management of gout. Issue 1 (25th July 2016)

Authors:
Richette, P; Doherty, M; Pascual, E; Barskova, V; Becce, F; Castañeda-Sanabria, J; Coyfish, M; Guillo, S; Jansen, T L; Janssens, H; Lioté, F; Mallen, C; Nuki, G; Perez-Ruiz, F; Pimentao, J; Punzi, L; Pywell, T; So, A; Tausche, A K; Uhlig, T
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 1(2017)
Page Start:
29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. EULAR recommendations for calcium pyrophosphate deposition. Part II: Management. Issue 4 (20th January 2011)

Authors:
Zhang, W; Doherty, M; Pascual, E; Barskova, V; Guerne, P-A; Jansen, T L; Leeb, B F; Perez-Ruiz, F; Pimentao, J; Punzi, L; Richette, P; Sivera, F; Uhlig, T; Watt, I; Bardin, T
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70:Issue 4(2011)
Page Start:
571
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Issue 4 (7th January 2011)

Authors:
Zhang, W; Doherty, M; Bardin, T; Barskova, V; Guerne, P-A; Jansen, T L; Leeb, B F; Perez-Ruiz, F; Pimentao, J; Punzi, L; Richette, P; Sivera, F; Uhlig, T; Watt, I; Pascual, E
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70:Issue 4(2011)
Page Start:
563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies. Issue 6 (14th July 2008)

Authors:
Kievit, W; Fransen, J; Adang, E M; Kuper, H H; Jansen, T L; De Gendt, C M A; De Rooij, D J R A M; Brus, H L M; van de Laar, M A F J; Van Riel, P C L M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 6(2009)
Page Start:
844
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Issue 5 (18th October 2010)

Authors:
Arts, E E A; Jansen, T L; Broeder, A Den; Vonkeman, H E; Dutmer, E; Van de Laar, M A F J; Van Riel, P L C M; Fransen, J
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70:Issue 5(2011)
Page Start:
877
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data. Issue 9 (3rd January 2008)

Authors:
Kievit, W; Adang, E M; Fransen, J; Kuper, H H; van de Laar, M A F J; Jansen, T L; De Gendt, C M A; De Rooij, D-J R A M; Brus, H L M; Van Oijen, P C M; Van Riel, P C L M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 67:Issue 9(2008)
Page Start:
1229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Issue 11 (10th April 2007)

Authors:
Kievit, W; Fransen, J; Oerlemans, A J M; Kuper, H H; van der Laar, M A F J; de Rooij, D J R A M; De Gendt, C M A; Ronday, K H; Jansen, T L; van Oijen, P C M; Brus, H L M; Adang, E M; van Riel, P L C M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 66:Issue 11(2007)
Page Start:
1473
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗